A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis

NCT04255069 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonalcoholic Steatohepatitis (NASH) With Fibrosis

Interventions

DRUG: Placebo
DRUG: Dose 1 JKB-122
DRUG: Dose 2 JKB-122

Sponsor

TaiwanJ Pharmaceuticals Co., Ltd